Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-18-032715
Filing Date
2018-07-17
Accepted
2018-07-17 16:26:27
Documents
2
Period of Report
2018-07-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1679
2 poalawlis.htm EX-24 6036
  Complete submission text file 0001140361-18-032715.txt   9006
Mailing Address
Business Address
LAWLIS V BRYAN (Reporting) CIK: 0001247681 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37722 | Film No.: 18956748

Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Issuer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations